SKI Market

Indian Indices

Sensex

85,335.40 114.80
( 0.13%)

Global Indices

Nasdaq

48,085.52 -302.55
(-0.63%)

Dow Jones

6,867.73 -49.51
(-0.72%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Kabra Drugs Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524322

INE323K01017

10.9633096

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

61.1

72.43

EPS(TTM)

Face Value()

Div & Yield %

0.5

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.64	0.00	0.01	0.00	0.00	0.02
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.64	0.00	0.01	0.00	0.00	0.02
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.00
Employee Cost	0.69	0.40	0.23	0.09	0.05	0.00
Other Manufacturing Expenses	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Administrative Expenses	0.94	0.30	0.09	0.08	0.10	0.05
Miscellaneous Expenses	0.08	0.03	0.02	0.01	0.00	0.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1.72	0.74	0.34	0.18	0.15	0.05
Operating Profit	-1.08	-0.74	-0.34	-0.18	-0.15	-0.03
Interest	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	-1.08	-0.74	-0.34	-0.18	-0.15	-0.03
Depreciation	0.01	0.00	0.00	0.01	0.03	0.03
Profit Before Tax	-1.09	-0.74	-0.34	-0.19	-0.18	-0.06
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	-1.09	-0.74	-0.34	-0.19	-0.18	-0.06
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	-1.09	-0.74	-0.34	-0.19	-0.18	-0.06
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	-5.86	-5.12	-4.78	-4.60	-4.42	-4.36
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-6.94	-5.86	-5.12	-4.78	-4.60	-4.42
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.46	-1.68	-0.77	-0.42	-0.41	-0.14
Earnings Per Share(Adj)-Unit Curr	-0.46	-1.68	-0.77	-0.42	-0.41	-0.14
Book Value-Unit Curr	10.40	-3.34	-1.67	-0.90	-0.47	-0.06
Book Value(Adj)-Unit Curr	10.40	-3.34	-1.67	-0.90	-0.47	-0.06

85,335.40 114.80 ( 0.13%)

48,085.52 -302.55 (-0.63%)

6,867.73 -49.51 (-0.72%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)